Table 3. Multivariate Cox regression analysis comparing primary to secondary AML.
| Parameter | Hazard ratio | 95% Confidence interval | P-value |
|---|---|---|---|
| Diagnosis (primary vs secondary AML) | 1.27 | 1.00–1.62 | 0.051 |
| Age (⩽60 vs>60) | 2.19 | 1.70–2.81 | <0.001 |
| Cytogenetic analysis (normal karyotype vs others) | 1.00 | 0.74–1.35 | 0.992 |
| Cytogenetic analysis (normal karyotype vs others) | 2.35 | 1.71–3.24 | <0.001 |
| Cytogenetic analysis (normal karyotype vs others) | 1.85 | 1.25–2.74 | 0.002 |
| WBC (⩽15 000 vs >15 000) | 1.44 | 1.12–1.84 | 0.004 |
| DNMT3A | 1.95 | 1.46–2.59 | <0.001 |
| ASXL1 | 1.72 | 1.19–2.48 | 0.004 |
| EZH2 | 2.18 | 1.20–3.97 | 0.011 |
| TP53 | 2.23 | 1.47–3.38 | <0.001 |
Abbreviations: AML, acute myeloid leukemia; WBC, white blood cell count.